Double Bond Pharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Double Bond Pharmaceutical
Access all reports
Double Bond Pharmaceutical International AB is a Sweden-based pharmaceutical company specializing in the development of innovative therapies for cancer and infectious diseases. The company focuses on utilizing advanced drug delivery technologies to improve the efficacy and safety of treatments. Double Bond Pharmaceutical’s research and development efforts aim to address unmet medical needs and provide targeted solutions for patients. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
DBP
Country
🇸🇪 Sweden